Cargando…

Behavioral and Transcriptomic Changes Following Brain-Specific Loss of Noradrenergic Transmission

Noradrenaline (NE) plays an integral role in shaping behavioral outcomes including anxiety/depression, fear, learning and memory, attention and shifting behavior, sleep-wake state, pain, and addiction. However, it is unclear whether dysregulation of NE release is a cause or a consequence of maladapt...

Descripción completa

Detalles Bibliográficos
Autores principales: Isingrini, Elsa, Guinaudie, Chloé, Perret, Léa, Guma, Elisa, Gorgievski, Victor, Blum, Ian D., Colby-Milley, Jessica, Bairachnaya, Maryia, Mella, Sébastien, Adamantidis, Antoine, Storch, Kai-Florian, Giros, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046559/
https://www.ncbi.nlm.nih.gov/pubmed/36979445
http://dx.doi.org/10.3390/biom13030511
_version_ 1785013703194705920
author Isingrini, Elsa
Guinaudie, Chloé
Perret, Léa
Guma, Elisa
Gorgievski, Victor
Blum, Ian D.
Colby-Milley, Jessica
Bairachnaya, Maryia
Mella, Sébastien
Adamantidis, Antoine
Storch, Kai-Florian
Giros, Bruno
author_facet Isingrini, Elsa
Guinaudie, Chloé
Perret, Léa
Guma, Elisa
Gorgievski, Victor
Blum, Ian D.
Colby-Milley, Jessica
Bairachnaya, Maryia
Mella, Sébastien
Adamantidis, Antoine
Storch, Kai-Florian
Giros, Bruno
author_sort Isingrini, Elsa
collection PubMed
description Noradrenaline (NE) plays an integral role in shaping behavioral outcomes including anxiety/depression, fear, learning and memory, attention and shifting behavior, sleep-wake state, pain, and addiction. However, it is unclear whether dysregulation of NE release is a cause or a consequence of maladaptive orientations of these behaviors, many of which associated with psychiatric disorders. To address this question, we used a unique genetic model in which the brain-specific vesicular monoamine transporter-2 (VMAT2) gene expression was removed in NE-positive neurons disabling NE release in the entire brain. We engineered VMAT2 gene splicing and NE depletion by crossing floxed VMAT2 mice with mice expressing the Cre-recombinase under the dopamine β-hydroxylase (DBH) gene promotor. In this study, we performed a comprehensive behavioral and transcriptomic characterization of the VMAT2DBHcre KO mice to evaluate the role of central NE in behavioral modulations. We demonstrated that NE depletion induces anxiolytic and antidepressant-like effects, improves contextual fear memory, alters shifting behavior, decreases the locomotor response to amphetamine, and induces deeper sleep during the non-rapid eye movement (NREM) phase. In contrast, NE depletion did not affect spatial learning and memory, working memory, response to cocaine, and the architecture of the sleep-wake cycle. Finally, we used this model to identify genes that could be up- or down-regulated in the absence of NE release. We found an up-regulation of the synaptic vesicle glycoprotein 2c (SV2c) gene expression in several brain regions, including the locus coeruleus (LC), and were able to validate this up-regulation as a marker of vulnerability to chronic social defeat. The NE system is a complex and challenging system involved in many behavioral orientations given it brain wide distribution. In our study, we unraveled specific role of NE neurotransmission in multiple behavior and link it to molecular underpinning, opening future direction to understand NE role in health and disease.
format Online
Article
Text
id pubmed-10046559
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100465592023-03-29 Behavioral and Transcriptomic Changes Following Brain-Specific Loss of Noradrenergic Transmission Isingrini, Elsa Guinaudie, Chloé Perret, Léa Guma, Elisa Gorgievski, Victor Blum, Ian D. Colby-Milley, Jessica Bairachnaya, Maryia Mella, Sébastien Adamantidis, Antoine Storch, Kai-Florian Giros, Bruno Biomolecules Article Noradrenaline (NE) plays an integral role in shaping behavioral outcomes including anxiety/depression, fear, learning and memory, attention and shifting behavior, sleep-wake state, pain, and addiction. However, it is unclear whether dysregulation of NE release is a cause or a consequence of maladaptive orientations of these behaviors, many of which associated with psychiatric disorders. To address this question, we used a unique genetic model in which the brain-specific vesicular monoamine transporter-2 (VMAT2) gene expression was removed in NE-positive neurons disabling NE release in the entire brain. We engineered VMAT2 gene splicing and NE depletion by crossing floxed VMAT2 mice with mice expressing the Cre-recombinase under the dopamine β-hydroxylase (DBH) gene promotor. In this study, we performed a comprehensive behavioral and transcriptomic characterization of the VMAT2DBHcre KO mice to evaluate the role of central NE in behavioral modulations. We demonstrated that NE depletion induces anxiolytic and antidepressant-like effects, improves contextual fear memory, alters shifting behavior, decreases the locomotor response to amphetamine, and induces deeper sleep during the non-rapid eye movement (NREM) phase. In contrast, NE depletion did not affect spatial learning and memory, working memory, response to cocaine, and the architecture of the sleep-wake cycle. Finally, we used this model to identify genes that could be up- or down-regulated in the absence of NE release. We found an up-regulation of the synaptic vesicle glycoprotein 2c (SV2c) gene expression in several brain regions, including the locus coeruleus (LC), and were able to validate this up-regulation as a marker of vulnerability to chronic social defeat. The NE system is a complex and challenging system involved in many behavioral orientations given it brain wide distribution. In our study, we unraveled specific role of NE neurotransmission in multiple behavior and link it to molecular underpinning, opening future direction to understand NE role in health and disease. MDPI 2023-03-10 /pmc/articles/PMC10046559/ /pubmed/36979445 http://dx.doi.org/10.3390/biom13030511 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Isingrini, Elsa
Guinaudie, Chloé
Perret, Léa
Guma, Elisa
Gorgievski, Victor
Blum, Ian D.
Colby-Milley, Jessica
Bairachnaya, Maryia
Mella, Sébastien
Adamantidis, Antoine
Storch, Kai-Florian
Giros, Bruno
Behavioral and Transcriptomic Changes Following Brain-Specific Loss of Noradrenergic Transmission
title Behavioral and Transcriptomic Changes Following Brain-Specific Loss of Noradrenergic Transmission
title_full Behavioral and Transcriptomic Changes Following Brain-Specific Loss of Noradrenergic Transmission
title_fullStr Behavioral and Transcriptomic Changes Following Brain-Specific Loss of Noradrenergic Transmission
title_full_unstemmed Behavioral and Transcriptomic Changes Following Brain-Specific Loss of Noradrenergic Transmission
title_short Behavioral and Transcriptomic Changes Following Brain-Specific Loss of Noradrenergic Transmission
title_sort behavioral and transcriptomic changes following brain-specific loss of noradrenergic transmission
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046559/
https://www.ncbi.nlm.nih.gov/pubmed/36979445
http://dx.doi.org/10.3390/biom13030511
work_keys_str_mv AT isingrinielsa behavioralandtranscriptomicchangesfollowingbrainspecificlossofnoradrenergictransmission
AT guinaudiechloe behavioralandtranscriptomicchangesfollowingbrainspecificlossofnoradrenergictransmission
AT perretlea behavioralandtranscriptomicchangesfollowingbrainspecificlossofnoradrenergictransmission
AT gumaelisa behavioralandtranscriptomicchangesfollowingbrainspecificlossofnoradrenergictransmission
AT gorgievskivictor behavioralandtranscriptomicchangesfollowingbrainspecificlossofnoradrenergictransmission
AT blumiand behavioralandtranscriptomicchangesfollowingbrainspecificlossofnoradrenergictransmission
AT colbymilleyjessica behavioralandtranscriptomicchangesfollowingbrainspecificlossofnoradrenergictransmission
AT bairachnayamaryia behavioralandtranscriptomicchangesfollowingbrainspecificlossofnoradrenergictransmission
AT mellasebastien behavioralandtranscriptomicchangesfollowingbrainspecificlossofnoradrenergictransmission
AT adamantidisantoine behavioralandtranscriptomicchangesfollowingbrainspecificlossofnoradrenergictransmission
AT storchkaiflorian behavioralandtranscriptomicchangesfollowingbrainspecificlossofnoradrenergictransmission
AT girosbruno behavioralandtranscriptomicchangesfollowingbrainspecificlossofnoradrenergictransmission